Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating upfront treatment with elotuzumab, carfilzomib, lenalidomide, and dexamethasone in multiple myeloma has completed…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Repeated HBO Therapy in Myeloma Patients Undergoing High-Dose Therapy and Auto-HCT [EARLY_Phase 1]
An early-phase clinical trial update reports the completion of a study assessing repeated hyperbaric oxygen therapy in multiple myeloma pati…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: A Plant-Based Whole-Foods Meal Delivery Service for Patients With Multiple Myeloma Undergoing Autologous Hematopoietic Cell Transplant [NA]
This is a completed clinical trial evaluating a plant-based whole-foods meal delivery service for patients with multiple myeloma undergoing …
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Evaluating Effectiveness of Powered Drill Bone Marrow Biopsy [NA]
A completed clinical trial from Emory University evaluating the effectiveness of a powered drill bone marrow biopsy in plasma cell myeloma (…
-
CLINICAL_TRIALS trial_result · 2025-09-02Clinical Trial Update: Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM [Phase 1, Phase 2]
Clinical trial update for a belantamab mafodotin sub-study in relapsed/refractory multiple myeloma, including monotherapy and combinations w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization [Phase 1]
Completed Phase 1 pharmacodynamic study evaluating the apheresis product from multiple myeloma patients undergoing quad-induction followed b…
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies [Phase 1]
The Phase 1 study evaluating AB308 in combination with AB122 in participants with advanced malignancies has been completed.
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant [Phase 1]
Phase 1 clinical trial evaluating recombinant human interleukin-7 (CYT107) for tumor clearance and immune reconstitution in multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Remission [Phase 2]
Phase 2 trial update of an allogeneic GM-CSF vaccine with lenalidomide in multiple myeloma patients in complete or near complete remission. …
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Testing Ipatasertib as Potentially Targeted Treatment in Cancers With AKT Genetic Changes (MATCH - Subprotocol Z1K) [Phase 2]
This Clinical Trial Update reports that ipatasertib is being tested as a targeted therapy for cancers with AKT genetic alterations in the NC…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Immunomodulatory Drugs (Lenalidomide With or Without Pomalidomide) in Combination With a Corticosteroid Drug (Dexamethasone) for the Treatment of Multiple Myeloma [Phase 2]
Phase 2 trial evaluating lenalidomide with or without pomalidomide in combination with dexamethasone for multiple myeloma; the study was ter…
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss
This clinical trial update reports the development and pilot testing of a new magnetic resonance imaging protocol to quantify multiple myelo…
-
CLINICAL_TRIALS trial_result · 2025-08-17Clinical Trial Update: Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant [Phase 1]
Phase 1 trial evaluating a combination of ibrutinib, lenalidomide, and dexamethasone in multiple myeloma patients ineligible for transplant;…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients.
This clinical trial update assesses the effects of daratumumab-containing induction on stem cell mobilization, collection, and engraftment i…
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma [Phase 3]
A Phase 3 trial evaluating pharmacokinetics, efficacy and safety of subcutaneous CT-P44 vs Darzalex Faspro in combination with lenalidomide …
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: Evaluation of the Use of Apixaban in Prevnetion of Thromboembolic Disease in Patients With Myeloma Trated With iMiDs [Phase 3]
Phase 3 trial evaluating apixaban for prevention of venous thromboembolism in patients with multiple myeloma treated with IMiDs has complete…
-
CLINICAL_TRIALS trial_result · 2025-08-13Clinical Trial Update: RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies [Phase 1]
A Phase 1 clinical trial update for RN1201 injection in relapsed/refractory CD19+/BCMA+ hematologic malignancies, currently not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma [NA]
A clinical trial evaluating the effects of early palliative care integration in patients with newly diagnosed multiple myeloma has completed…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment. [Phase 2]
Phase 2 trial update evaluating intensified treatment with carfilzomib in multiple myeloma patients who remain PET-positive after first-line…
-
CLINICAL_TRIALS trial_result · 2025-08-08Clinical Trial Update: ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals [NA]
A clinical trial (ImmunoCARE) evaluated rapid, accurate COVID-19 testing to reduce hospitalizations among immunocompromised individuals. The…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells [Phase 2]
This clinical trial update reports long-term follow-up data from patients treated with Autolus' autologous CAR T cell therapy in multiple my…
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 study evaluating Modakafusp Alfa in combination with Daratumumab for adults with relapsed or refractory multiple myeloma has been …
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: A Study of Modakafusp Alfa in Adult Participants With Multiple Myeloma [Phase 1]
Phase 1 study evaluating Modakafusp alfa in adults with multiple myeloma has been terminated, and trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-08-05Clinical Trial Update: Phase I Trial of GR1803 Injection in Patients With RRMM [Phase 1, Phase 2]
Phase I/II clinical trial update for GR1803 injection in relapsed/refractory multiple myeloma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: A Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 study evaluating the safety and preliminary efficacy of DKN-01 in combination with lenalidomide and dexamethasone for relapsed or re…